Montanova Capital LLC Purchases 2,300 Shares of Intuitive Surgical, Inc. $ISRG

Montanova Capital LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.4% during the second quarter, Holdings Channel reports. The firm owned 13,600 shares of the medical equipment provider’s stock after purchasing an additional 2,300 shares during the period. Montanova Capital LLC’s holdings in Intuitive Surgical were worth $5,408,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Deutsche Bank AG boosted its holdings in Intuitive Surgical by 9.6% during the 4th quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider’s stock worth $862,108,000 after acquiring an additional 132,966 shares during the last quarter. Jag Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth $18,771,000. Sycomore Asset Management purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $10,730,000. Plato Investment Management Ltd bought a new stake in Intuitive Surgical in the 2nd quarter worth about $4,315,000. Finally, AustralianSuper Pty Ltd increased its stake in Intuitive Surgical by 348.6% in the 4th quarter. AustralianSuper Pty Ltd now owns 50,400 shares of the medical equipment provider’s stock valued at $28,545,000 after buying an additional 39,166 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on ISRG. Wells Fargo & Company reissued an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. HSBC downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a research note on Thursday, July 30th. Robert W. Baird lowered their target price on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. Bank of America cut their price target on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Finally, The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Twenty-two analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $508.68.

Insider Activity

In other Intuitive Surgical news, Director Amy L. Ladd sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director directly owned 251 shares in the company, valued at $95,129. This represents a 61.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 11,658 shares of company stock valued at $4,649,835 over the last ninety days. 0.60% of the stock is owned by insiders.

Intuitive Surgical Stock Up 1.1%

Shares of NASDAQ ISRG opened at $376.86 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The business has a 50-day simple moving average of $384.07 and a two-hundred day simple moving average of $431.50. The company has a market cap of $133.14 billion, a P/E ratio of 43.17, a P/E/G ratio of 2.69 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the firm earned $1.81 EPS. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.